PLoS ONE (Jan 2014)

Comparison of angiogenic, cytoprotective, and immunosuppressive properties of human amnion- and chorion-derived mesenchymal stem cells.

  • Kenichi Yamahara,
  • Kazuhiko Harada,
  • Makiko Ohshima,
  • Shin Ishikane,
  • Shunsuke Ohnishi,
  • Hidetoshi Tsuda,
  • Kentaro Otani,
  • Akihiko Taguchi,
  • Toshihiro Soma,
  • Hiroyasu Ogawa,
  • Shinji Katsuragi,
  • Jun Yoshimatsu,
  • Mariko Harada-Shiba,
  • Kenji Kangawa,
  • Tomoaki Ikeda

DOI
https://doi.org/10.1371/journal.pone.0088319
Journal volume & issue
Vol. 9, no. 2
p. e88319

Abstract

Read online

Although mesenchymal stem cells (MSCs) can be obtained from the fetal membrane (FM), little information is available regarding biological differences in MSCs derived from different layers of the FM or their therapeutic potential. Isolated MSCs from both amnion and chorion layers of FM showed similar morphological appearance, multipotency, and cell-surface antigen expression. Conditioned media obtained from amnion- and chorion-derived MSCs inhibited cell death caused by serum starvation or hypoxia in endothelial cells and cardiomyocytes. Amnion and chorion MSCs secreted significant amounts of angiogenic factors including HGF, IGF-1, VEGF, and bFGF, although differences in the cellular expression profile of these soluble factors were observed. Transplantation of human amnion or chorion MSCs significantly increased blood flow and capillary density in a murine hindlimb ischemia model. In addition, compared to human chorion MSCs, human amnion MSCs markedly reduced T-lymphocyte proliferation with the enhanced secretion of PGE2, and improved the pathological situation of a mouse model of acute graft-versus-host disease. Our results highlight that human amnion- and chorion-derived MSCs, which showed differences in their soluble factor secretion and angiogenic/immuno-suppressive function, could be ideal cell sources for regenerative medicine.